Clinical trial
Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord Injury
NCT05018793 is registered in ClinicalTrials.gov with The Foundation for Orthopaedics and Regenerative Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord Injury
- Lead sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 1, 2024
- Completion date
- December 31, 2028
- Enrollment
- 15 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.